Collectively, these results clearly demonstrate that LCN2 suppresses proliferation, metastasis/invasion, and EMT by attenuating the promoter activity of NF-κB in CRC, which inhibits the NF-κB/snail signaling pathway. This evidence concerns the gene LCN2 and colorectal carcinoma.